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Summary
In the gene differential expression analysis of Single Cell RNA-seq data, the aim is to sort out 
functional gene sets for specific diseases or traits of interest. The mean-variance relationship of the 
log-counts is also evaluated to generate precision weights for empirical Bayes analysis. We demon-
strate through a gene set test study that the functional gene sets identified by the permutation 
tests on samples of different biological conditions are largely different. The permutation-based 
test uses the transformation of coefficient of variation (cv) as a novel variability measure and 
the empirical Bayes statistical methods borrow strength between genes for exact type I error 
rate control. We also reduce the mean variance trend incurred by scRNA-deq data’s violation of 
the normal assumption of intermediate linear modeling steps. We apply the methodology to two 
samples of single cell transcriptomics from lymphoid organs (spleen) of humanized mice with one 
Mock mouse and one HIV-1 infected mouse. Our results agree with previous findings and in the
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case of the HIV-infected mouse dataset suggest an additional perspective of interest.
Key words: single cell RNA-seq data; gene differential expression analysis; HIV-infected humanized mouse;
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1. Introduction
Genetics studies [1] found that in many human diseases, some genes have a significant increase or
decrease in expression variability (variance). As these observed changes in expression variability
may be caused by alteration of the underlying expression dynamics in response to the diseases,
such differential variability patterns may also spark further biologically meaningful discovery. One
statistical solution to capture these functional genes regulating disease-related cells is to conduct
“appropriate” tests on the gene expression variability and sort out statistically significant results.
In particular, tests aiming at differential expression analysis of a set of genes are generalized as
“gene set tests” where a single P-value is assigned to the set of genes as a unit, and gene set
tests usually analyze differential expression either across samples (e.g. infected individuals v.s.
uninfected individuals) or across genes.
Currently, there are three popular methods for gene set testing: (1) gene permutation test, (2)
CAMERA, and (3) parametric test/PAGE. First, the gene permutation test only assumes that
individual genes are independent from each other [2], but the permutation test is limited to a
small number of group comparisons due to computational demands. Second, CAMERA is based
on the gene permutation test while using an estimate of the inter-gene correlation from the data
to adjust the gene set test statistic [3]. However, estimating the inter-gene correlation incurs loss
of statistical power which is especially bad when the test set only contains a small number of
genes. Third, the parametric analysis of gene set enrichment (PAGE) could identify significant
variability changes from microarray data irrespective of analysis methods or microarray platforms,
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but it requires the distribution of the test set to be normal [4]. On the data side, current gene
differential expression studies that employed the above methods are primarily based on bulk RNA-
deq data or microarray. Bulk RNA-seq or microarray data gather the expression information of
RNAs from large and mixed cell populations, while such measurements may obscure biologically
relevant differences between individual cells [5].
Because of the aforementioned limitations in both existing gene-set-test methods and bulk
RNA-seq/microarray data as the test set, a UNC master graduate Yiling Liu proposed a novel
gene set testing procedure across genes to analyze gene expression variability based on single cell
RNA-seq (scRNA-seq) data [6]. Compared to bulk RNA-seq, scRNA-seq examines the sequence
information from individual cells and can reveal regulatory relationships between genes that may
be obscured by bulk RNA-seq data. Liu’s approach first uses the gene level coefficient of variation
(cv) to adjust mean-variance effects [7], and then applies a tranformation of cv as the test statistic
in a permutation gene set test. However, the mean-variance trend that reflects the mean effects
on variability persists in her results and the method needs more power to control the type I error
rate.
In this text, the author evaluates Liu’s methodology based on zero-inflated scRNA-seq data
that have a bimodal distribution similar to Liu’s but much smaller gene expression values: First,
a traditional voom procedure is performed on the data to analyze read counts and handle the
mean-variance relationship before conducting differential expression analysis. Then, because the
models in traditional voom methods target at unimodally distributed bulk RNA-deq data, a
hurdel Guassian model - one of the novel zero-inflated models - is fitted on our data by MAST
[8]. Next, the cv across genes (rows) can be derived from the gene variability estimated by the
hurdle model, and a summary measure of this cv is proposed as the test statistic in the subsequent
gene permutation test to distinguish functional gene sets. The gene permutation test is chosen
against CAMERA and PAGE because our bimodal zero-inflated data violate the assumption of
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normal distribution in PAGE and CAMERA causes higher loss of power. Finally, results of the
permutation test on the HIV-infected sample and the normal sample are compared to assess
the biological value of the method. If there exist verified functional gene sets for HIV among
the significant ones identified from the HIV-infected sample and exist distinct combinations of
functional gene sets for the two samples, then the method may suggest that some other significant
gene sets, though yet to be discovered by biology evidence, play a role in the genetic mechanisms
of the diseases.
2. Methods
2.1 Voom: Reduce the mean-variance trend
Following the voom procedure in R’s Limma package, the author first performs a log-transformation
of the counts to estimate the mean-variance relationship between the residual standard deviations
and the average log-counts through ordinary least squares (OLS) regresssion. Second, a precision
weight is generated based on the linear function defined by the LOWESS curve [6], which is
applied to weighted least squares (WLS) regression. Finally, the mean-variance trend is reduced
between the residual standard deviations from WLS and the average log-counts.
2.1.1 Log transformation. Given the scRNA-seq count matix, let rgc be the expression count
per gene g ∈ {1, ..., G} and per cell c ∈ {1, ..., N}. Then, define the log transform of rgc to be
ygc = log2(rgc + 1). This step is necessary to make the data distribution more normal for linear
regression.
2.1.2 Linear regression. Let X = [xc] be the covariate vector and βg the coefficients of X per
gene. Define the linear model of log-counts v.s. covariates to be E(yg) = Xβg. This model is
fitted by OLS regression across genes to obtain the regression estimated coefficients βˆg and the
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residual standard deviation per gene sg. Then, calculate the predicted log-counts ŷg and the log-
count average ŷg. Since all cells are treated as one sample, each xc is a unit vector and thus the
estimated coefficient βˆg is the grand mean of log-counts across genes and the residual standard
deviation sg is the empirical variance of each gene [6].
2.1.3 Precision weight. Voom uses a LOWESS curve fitted to
√
sg as a function of ŷg for
generating more smooth mean-variance plots. The LOWESS curve spans the trend line through
a majority of sg points and is statistically robust. Subsequently, a piecewise linear function lo(ŷgc)
is defined by the LOWESS curve to produce the precision weight: wgc = lo(ŷgc)
−4.
2.1.4 Trend elimination. The mean-variance trend is estimated both before and after voom.
Before voom, set λ = E(r) where r is the expression count matrix, and supposes var(r) = r+φr
where φ is the dispersion parameter [7]. When elements of r are large, claim that log2(r) ≈ λ+ r−λλ
and thus var(y) = var(log2(r)) =
1
λ + φ [6]. With the dispersion parameter fixed, the variance
of log-counts decreases as the expected mean count increases. After voom, the 2.1.3 precision
weights are applied to the linear model defined in 2.1.2 to generate “WLS treated sg”. As a
result, the mean-variance trend of our data is noticeably reduced but not eliminated.
2.2 MAST: Estimate gene variability for gene set testing
MAST uses the hurdle model to estimate gene variability and is especially designed for bimodally
distributed zero-inflated scRNA-seq data.
2.2.1 scRNA-seq hurdle model. The log count log2(r + 1) expression matrix is modeled as a
two-part generated regression model [9]. First, the gene expression rate is modeled using logistic
regression. Second, conditioning on a cell expressing the gene, the expression level is modeled
as Guassian. Let the scRNA-seq expression matrix be Y = [ygc], and define its indicator as a
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discrete variable Z = [zgc] where
zgc =
{
0 if ygc = 0
1 if ygc > 0
(2.1)
Subsequently, logistic regression models are fitted on Z and a Guassian linear model for the
continuous variable (Y |Z = 1) as follows:
logit(Pr(Zgc = 1)) = Xcβ
D
g (2.2)
Pr(Ygc = y|Zgc = 1) = N(XiβCg , σ2g) (2.3)
Only residual standard deviations from the continuous model are used as the gene variability
estimates for the next section’s permutation test, because discrete counts are mostly caused by
technical errors and are not biologically meaningful.
2.3 Summary measure of variance
Recall the definition of cv: cv =
σ
µ . Given the gene variability estimates obtained from MAST,
cv can be derived as the mean adjusted variance. Because the distribution of cv across genes is
right-skewed, every cvg is averaged to give an approximately normal distribution. Thus, define
Vs =
√
cvg, where s ∈ {1, ..., S} represents the index of gene sets, to be the summary measure of
cv across genes for the subsequent gene set test.
2.4 Gene permutation test: Single out functional gene sets
Based on the gene permutation test assumption that genes are independent from each other, a
one-tailed hypothesis test is evaluated:
H0 : Vs = Vrs v.s. Ha : Vs > Vrs
where rs indicates the random set. Specifically, a random set is constructed by randomly sampling
1000 gene groups of the same size as the gene set s. Then, the Vs is permuted together with the
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1000 Vrs to compute P-values as follows:
ps = Pr(Vrs > Vs)
The cut-off point for significance is α = 0.05. Finally, gene sets with p < 0.05 are singled out
as functional gene sets.
3. Results
3.1 Data set description
This text evaluates the methodology based on two samples of single cell transcriptomics from
lymphoid organs (spleen) of humanized mice [9]. One mouse is Mock and the other mouse is HIV-
1 infected. The 10X GENOMICS R© GemCode was used to ensure approximately 100k reads/cell
and a median of approximately 1.5k genes/cell analyzed. There are about 2,000 cells per sample.
About 7 cell types can be identified in each sample. In details, the HIV-1 infected sample matrix
includes 32,738 genes and 2,692 cells, and the mock sample matrix includes 32,738 genes and
2,000 cells. Meanwhile, over 80% of genes have more than 90% zero counts across cells such that
the zero-inflated data distribute bimodally as below:
Fig. 1. Typical distribution of gene expression.
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3.2 The mean-variance trend reduced by voom
Before voom, genes with over 99% raw counts equal to 0 are filtered because counts near 0 have
very low standard deviations. The resulting scRNA-seq data matrix includes 3,035 genes and 1,998
cells. The mean-variance trend before voom looks like a down parabola, highly non-horizontal:
Fig. 2. scRNA-seq MV trend before Voom.
After voom, the mean-variance is reduced to be a slightly increasing flat curve but is not
eliminated:
Fig. 3. scRNA-seq MV trend after Voom.
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The MV trend persists after voom because voom relies on large counts of gene expressions
to eliminate the mean-variance effects but the counts in our zero-inflated scRNA-seq data are
small. In addition, the right-skewed distribution of our data violates the normal assumption of
the WLS regression during the trend elimination process. Hence, MAST is used as a more proper
model to estimate the gene variability of our interest.
3.3 The mean variance trend generated by MAST
The gene variability is first estimated by the hurdle model in R’s MAST package. Then, the last
two steps in voom (2.1.3 and 2.1.4) are repeated to eliminate the MV trend. Before adding the
precision weights, the M-CV relationship between cv (the summary meansure of gene variability
in MAST) and mean log-counts is plotted as Fig. 4.
Fig. 4. MAST: Mean-CV trend.
Fig. 4 has the shape of a down parabola similar to the mean-variance trend before voom since
cv =
σ
µ . Next, cv is used as the precision weights to estimate coefficients through WLS regression,
and the mean-variance trend between coefficient estimates and residual standard deviations is
given in Fig. 5:
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Fig. 5. MAST: Coeffcient-residual plot after WLS.
In comparison, the mean-variance effects after the WLS adjustment look like that they have
been reinforced instead of being reduced. Thus, a summary measure of cv is proposed as the
alternative variability measure for gene set testing.
3.4 Summary measure of variance
First, we examine the distribution histogram of cv across genes:
Fig. 6. CV Histogram for all genes.
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As the original cv histogram is right-skewed, a transformation of cv to its square root is
performed, and the resulting distrbution is shown below:
Fig. 7.
√
cv Histogram for all genes.
Given the almost normal distribution of
√
cv across genes, the mean
√
cv can be a more
proper summary measure of every gene set and is used as the test statistic for the subsequent
gene permutation test.
3.5 Significant gene sets from the gene permutation test
The permutation test across genes for the HIV-1 infected sample identifies 37 significant gene
sets from 941 gene sets filtered by a 30% cut-off of gene proportions in the orginal set. Fig. 8
shows the 28 gene sets with smallest P-values from cells of the HIV-1 infected mouse. The 22th
and 23th rows of Fig. 8 called “HEMATOPOIETIC STEM CELL UP/DN” are the “up” and
“down” regulated genes, and they are required in the hematopoietic stem cell which has long
been hypothesized to be a target of HIV infection [10].
In contrast, the permutaion test results from the Mock mouse sample (Fig. 9) present a
distinct rank of significant gene sets where the verified functional gene sets “HEMATOPOI-
ETIC STEM CELL UP/DN” have p > 0.05.
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Fig. 8. Significant gene sets in HIV-1 infected humanized mouse.
Fig. 9. Significant gene sets in normal humanized mouse.
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4. Discussion
In the results section, the existence of biologically verified functional gene sets among signigicant
test results sorted out for the infected individual agrees with Liu’s findings [6], and the distinction
of significant gene sets between the two samples suggests that some other functional gene sets
identified by the methodology, though yet to be discovered by biology evidence, may play a role
in the underlying genetic mechanisms of the diseases.
For the voom method, one probable reason why the parabola-shaped mean-variance (MV)
trend was reduced by voom to a slightly increasing line but was not eliminated is that the math
deduction for elimination assumes large expression counts to approximate log-counts while our
zero-inflated scRNA-seq data have small counts. Then, MAST methods were employed to fit a
zero-inflated model. One problem occured that the WLS adjustment causes the mean-variance
trend to grow even stronger as an increasing curve. Thus, the cv was proposed as an alternative
summary measure of the gene variability across genes to estimate the mean effects on variances.
Because of the right-skewed distribution of cv for all genes, cv was transformed to
√
cv that
distributes normally and serves as the test statistic for the gene permutation test.
There are also limitations in this text. First, the choice of
√
cv as an alternative measure
estimated for differential expression analysis due to the failure of weight adjustments for elim-
inating the MV trend was based on empirical evidence so that this transformation could be
arbitrary or ad hoc. Future works focus on mathematical derivation of the precision weights are
expected. Second, the gene permutation test assumes that gene sets are independent from each
other so inter-gene correlations were not considered. Future research should add correlations be-
tween genes for gene variability estimation and possibly adjust the variance inflation factor to
improve statistical power.
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5. Software
Software in the form of R code, together with two sample input data sets and complete docu-
mentation is available on request from the corresponding author (hejies@unc.edu).
References
1. Ho, J. W., Stefani, M., Dos Remedios, C. G., and Charleston, M. A. (2008). Differential
variability analysis of gene expression and its application to human diseases. Bioinformatics,
24 (13), i390-i398.
2. Phipson, B., and Smyth, G. K. (2010). Permutation P-values should never be zero: calcu-
lating exact P-values when permutations are randomly drawn. Statistical applications in
genetics and molecular biology, 9 (1).
3. Wu, D., and Smyth, G. K. (2012). Camera: a competitive gene set test accounting for
inter-gene correlation. Nucleic acids research, 40 (17), e133-e133.
4. Kim, S. Y., and Volsky, D. J. (2005). PAGE: parametric analysis of gene set enrichment.
BMC bioinformatics, 6 (1), 144.
5. Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H.,
... and Louis, D. N. (2014). Single-cell RNA-seq highlights intratumoral heterogeneity in
primary glioblastoma. Science, 344 (6190), 1396-1401.
6. Liu, Y. (2018). Exploration of gene expression variability in single cell RNAseq data for
gene set tests (Master’s thesis). Retrieved from UNC Department of Biostatistics Student
Theses and Dissertations Database.
7. Law, C. W., Chen, Y., Shi, W., and Smyth, G. K. (2014). voom: Precision weights unlock
linear model analysis tools for RNA-seq read counts. Genome biology, 15 (2), R29.
Gene differential expression in single cell RNA-seq data 15
8. Finak, G., McDavid, A., Yajima, M., Deng, J., Gersuk, V., Shalek, A. K., ... and Linsley, P.
S. (2015). MAST: a flexible statistical framework for assessing transcriptional changes and
characterizing heterogeneity in single-cell RNA sequencing data. Genome biology, 16 (1),
278.
9. Cheng L., Ma J., Li J., Li D., Li G., Li F., Zhang Q., Yu H., Yasui F., Ye C., Tsao L.C.,
Hu Z., Su L., and Zhang L. (2017). Blocking type I interferon signaling enhances T cell
recovery and reduces HIV-1 reservoirs. J Clin Invest, 127 (1):269-79. doi: 10.1172/JCI90745.
PubMed PMID: 27941247; PMCID: PMC5199717
10. Jaatinen, T., Hemmoranta, H., Hautaniemi, S., Niemi, J., Nicorici, D., Laine, J., ... and
Partanen, J. (2006). Global gene expression profile of human cord blood–derived CD133+
cells. Stem cells, 24 (3), 631-641.
